$ENZN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ENZON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ENZON PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ENZON PHARMACEUTICALS, INC. for free.
Page: < prev 1 2 3 4 5 6 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 12 2008 | ENZN | ENZON PHARMACEUTIC ... | HORAK IVAN D | EVP, R&D, Chief Sci ... | Buy | M | 0.00 | 15,000 | 0 | 106,000 | 91 K to 106 K (+16.48 %) |
Aug 12 2008 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Option Exercise | S | 9.55 | 3,000,000 | 28,650,000 | 4,712,041 | |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Option Exercise | M | 0.00 | 1,105 | 0 | 1,106 | |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Option Exercise | M | 0.00 | 3,172 | 0 | 6,346 | |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Option Exercise | M | 0.00 | 1,255 | 0 | 0 | |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Buy | M | 0.00 | 1,105 | 0 | 30,825 | 29.7 K to 30.8 K (+3.72 %) |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Buy | M | 0.00 | 3,172 | 0 | 29,720 | 26.5 K to 29.7 K (+11.95 %) |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Buy | M | 0.00 | 1,255 | 0 | 26,548 | 25.3 K to 26.5 K (+4.96 %) |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Grant | A | 0.00 | 10,417 | 0 | 25,293 | 14.9 K to 25.3 K (+70.03 %) |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Option Exercise | M | 0.00 | 1,105 | 0 | 1,106 | |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Option Exercise | M | 0.00 | 3,172 | 0 | 6,346 | |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Option Exercise | M | 0.00 | 1,255 | 0 | 0 | |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Buy | M | 0.00 | 1,105 | 0 | 15,973 | 14.9 K to 16 K (+7.43 %) |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Buy | M | 0.00 | 3,172 | 0 | 14,868 | 11.7 K to 14.9 K (+27.12 %) |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Buy | M | 0.00 | 1,255 | 0 | 11,696 | 10.4 K to 11.7 K (+12.02 %) |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Grant | A | 0.00 | 10,417 | 0 | 10,441 | 24 to 10.4 K (+43,404.17 %) |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Option Exercise | M | 0.00 | 1,105 | 0 | 1,106 | |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Option Exercise | M | 0.00 | 3,172 | 0 | 6,346 | |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Option Exercise | M | 0.00 | 1,255 | 0 | 0 | |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Buy | M | 0.00 | 1,105 | 0 | 102,024 | 100.9 K to 102 K (+1.09 %) |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Buy | M | 0.00 | 3,172 | 0 | 100,919 | 97.7 K to 100.9 K (+3.25 %) |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Buy | M | 0.00 | 1,255 | 0 | 97,747 | 96.5 K to 97.7 K (+1.30 %) |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Grant | A | 0.00 | 10,417 | 0 | 96,492 | 86.1 K to 96.5 K (+12.10 %) |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | Geltosky John | Director | Grant | A | 0.00 | 10,417 | 0 | 18,760 | 8.3 K to 18.8 K (+124.86 %) |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | MICATI VICTOR P | Director | Option Exercise | M | 0.00 | 1,105 | 0 | 1,106 | |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | MICATI VICTOR P | Director | Option Exercise | M | 0.00 | 3,172 | 0 | 6,346 | |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | MICATI VICTOR P | Director | Option Exercise | M | 0.00 | 1,255 | 0 | 0 | |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | MICATI VICTOR P | Director | Buy | M | 0.00 | 1,105 | 0 | 21,130 | 20 K to 21.1 K (+5.52 %) |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | MICATI VICTOR P | Director | Buy | M | 0.00 | 3,172 | 0 | 20,025 | 16.9 K to 20 K (+18.82 %) |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | MICATI VICTOR P | Director | Buy | M | 0.00 | 1,255 | 0 | 16,853 | 15.6 K to 16.9 K (+8.05 %) |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | MICATI VICTOR P | Director | Grant | A | 0.00 | 10,417 | 0 | 15,598 | 5.2 K to 15.6 K (+201.06 %) |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | ANDO GORAN | Director | Option Exercise | M | 0.00 | 1,105 | 0 | 1,106 | |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | ANDO GORAN | Director | Option Exercise | M | 0.00 | 3,172 | 0 | 6,346 | |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | ANDO GORAN | Director | Option Exercise | M | 0.00 | 1,255 | 0 | 0 | |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | ANDO GORAN | Director | Buy | M | 0.00 | 1,105 | 0 | 21,130 | 20 K to 21.1 K (+5.52 %) |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | ANDO GORAN | Director | Buy | M | 0.00 | 3,172 | 0 | 20,025 | 16.9 K to 20 K (+18.82 %) |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | ANDO GORAN | Director | Buy | M | 0.00 | 1,255 | 0 | 16,853 | 15.6 K to 16.9 K (+8.05 %) |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | ANDO GORAN | Director | Grant | A | 0.00 | 10,417 | 0 | 15,598 | 5.2 K to 15.6 K (+201.06 %) |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | SALISBURY ROBERT C | Director | Option Exercise | M | 0.00 | 1,105 | 0 | 1,106 | |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | SALISBURY ROBERT C | Director | Option Exercise | M | 0.00 | 3,172 | 0 | 6,346 | |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | SALISBURY ROBERT C | Director | Option Exercise | M | 0.00 | 1,255 | 0 | 0 | |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | SALISBURY ROBERT C | Director | Buy | M | 0.00 | 1,105 | 0 | 25,161 | 24.1 K to 25.2 K (+4.59 %) |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | SALISBURY ROBERT C | Director | Buy | M | 0.00 | 3,172 | 0 | 24,056 | 20.9 K to 24.1 K (+15.19 %) |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | SALISBURY ROBERT C | Director | Buy | M | 0.00 | 1,255 | 0 | 20,884 | 19.6 K to 20.9 K (+6.39 %) |
Jul 03 2008 | ENZN | ENZON PHARMACEUTIC ... | SALISBURY ROBERT C | Director | Grant | A | 0.00 | 10,417 | 0 | 19,629 | 9.2 K to 19.6 K (+113.08 %) |
Jun 02 2008 | ENZN | ENZON PHARMACEUTIC ... | Geltosky John | Director | Option Exercise | A | 8.99 | 22,930 | 206,141 | 22,930 | |
Jun 02 2008 | ENZN | ENZON PHARMACEUTIC ... | Geltosky John | Director | Grant | A | 8.99 | 8,343 | 75,004 | 8,343 | 0 to 8.3 K |
May 13 2008 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Option Exercise | M | 7.40 | 15,000 | 111,000 | 0 | |
May 13 2008 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Sell | S | 9.49 | 15,000 | 142,281 | 24 | 15 K to 24 (-99.84 %) |
May 13 2008 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Buy | M | 7.40 | 15,000 | 111,000 | 15,024 | 24 to 15 K (+62,500.00 %) |
May 13 2008 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Option Exercise | M | 0.00 | 4,500 | 0 | 10,500 | |
May 13 2008 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Buy | M | 0.00 | 4,500 | 0 | 116,122 | 111.6 K to 116.1 K (+4.03 %) |
May 13 2008 | ENZN | ENZON PHARMACEUTIC ... | del Campo Ralph | EVP - Technical Ope ... | Option Exercise | M | 0.00 | 4,500 | 0 | 10,500 | |
May 13 2008 | ENZN | ENZON PHARMACEUTIC ... | del Campo Ralph | EVP - Technical Ope ... | Buy | M | 0.00 | 4,500 | 0 | 121,156 | 116.7 K to 121.2 K (+3.86 %) |
May 13 2008 | ENZN | ENZON PHARMACEUTIC ... | Davit Paul Stephen | Exec. Vice Pres. HR | Option Exercise | M | 0.00 | 4,500 | 0 | 10,500 | |
May 13 2008 | ENZN | ENZON PHARMACEUTIC ... | Davit Paul Stephen | Exec. Vice Pres. HR | Buy | M | 0.00 | 4,500 | 0 | 57,603 | 53.1 K to 57.6 K (+8.47 %) |
May 12 2008 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Sell | S | 9.47 | 1,887 | 17,870 | 24 | 1.9 K to 24 (-98.74 %) |
May 12 2008 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Sell | S | 9.45 | 3,600 | 34,020 | 1,911 | 5.5 K to 1.9 K (-65.32 %) |
Jan 18 2008 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | EVP, FINANCE, CFO | Grant | A | 0.00 | 55,000 | 0 | 109,500 | 54.5 K to 109.5 K (+100.92 %) |
Jan 18 2008 | ENZN | ENZON PHARMACEUTIC ... | HORAK IVAN D | EVP, R&D, Chief Sci ... | Grant | A | 0.00 | 55,000 | 0 | 91,000 | 36 K to 91 K (+152.78 %) |
Jan 18 2008 | ENZN | ENZON PHARMACEUTIC ... | BUCHALTER JEFFREY H | Chairman, CEO & Pre ... | Grant | A | 0.00 | 200,000 | 0 | 403,234 | 203.2 K to 403.2 K (+98.41 %) |
Jan 18 2008 | ENZN | ENZON PHARMACEUTIC ... | Davit Paul Stephen | EVP, Human Resource ... | Grant | A | 0.00 | 10,000 | 0 | 50,656 | 40.7 K to 50.7 K (+24.60 %) |
Jan 18 2008 | ENZN | ENZON PHARMACEUTIC ... | del Campo Ralph | EVP, Technical Oper ... | Grant | A | 0.00 | 55,000 | 0 | 114,156 | 59.2 K to 114.2 K (+92.97 %) |
Jan 04 2008 | ENZN | ENZON PHARMACEUTIC ... | SALISBURY ROBERT C | Director | Option Exercise | A | 9.37 | 21,227 | 198,897 | 21,227 | |
Jan 04 2008 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Option Exercise | A | 9.37 | 21,227 | 198,897 | 21,227 | |
Jan 04 2008 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Option Exercise | A | 9.37 | 21,227 | 198,897 | 21,227 | |
Jan 04 2008 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Option Exercise | A | 9.37 | 21,227 | 198,897 | 21,227 | |
Jan 04 2008 | ENZN | ENZON PHARMACEUTIC ... | MICATI VICTOR P | Director | Option Exercise | A | 9.37 | 21,227 | 198,897 | 21,227 | |
Jan 04 2008 | ENZN | ENZON PHARMACEUTIC ... | ANDO GORAN | Director | Option Exercise | A | 9.37 | 21,227 | 198,897 | 21,227 | |
Aug 21 2007 | ENZN | ENZON PHARMACEUTIC ... | BUCHALTER JEFFREY H | Chairman, CEO & Pre ... | Buy | P | 7.46 | 4,590 | 34,241 | 203,234 | 198.6 K to 203.2 K (+2.31 %) |
Aug 21 2007 | ENZN | ENZON PHARMACEUTIC ... | BUCHALTER JEFFREY H | Chairman, CEO & Pre ... | Buy | P | 7.45 | 410 | 3,055 | 198,644 | 198.2 K to 198.6 K (+0.21 %) |
Aug 15 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Sell | J | 6.52 | 50,000 | 326,000 | 0 | 50 K to 0 (-100.00 %) |
Aug 15 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 6.52 | 50,000 | 326,000 | 50,000 | 0 to 50 K |
Aug 15 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Sell | J | 6.49 | 50,000 | 324,500 | 0 | 50 K to 0 (-100.00 %) |
Aug 15 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 6.49 | 50,000 | 324,500 | 50,000 | 0 to 50 K |
Aug 15 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Sell | J | 6.46 | 2,343 | 15,136 | 0 | 2.3 K to 0 (-100.00 %) |
Aug 15 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 6.46 | 2,343 | 15,136 | 2,343 | 0 to 2.3 K |
Aug 06 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Sell | J | 7.21 | 60,000 | 432,600 | 0 | 60 K to 0 (-100.00 %) |
Aug 06 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 7.21 | 60,000 | 432,600 | 60,000 | 0 to 60 K |
Jul 26 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Sell | J | 7.71 | 55,000 | 424,050 | 0 | 55 K to 0 (-100.00 %) |
Jul 26 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 7.71 | 55,000 | 424,050 | 55,000 | 0 to 55 K |
Jul 18 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Sell | J | 7.75 | 22,192 | 171,988 | 0 | 22.2 K to 0 (-100.00 %) |
Jul 18 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 7.75 | 22,192 | 171,988 | 22,192 | 0 to 22.2 K |
Jul 13 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Sell | J | 7.71 | 500 | 3,855 | 0 | 500 to 0 (-100.00 %) |
Jul 13 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 7.71 | 500 | 3,855 | 500 | 0 to 500 |
Jul 13 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Sell | J | 7.73 | 54,013 | 417,520 | 0 | 54 K to 0 (-100.00 %) |
Jul 13 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 7.73 | 54,013 | 417,520 | 54,013 | 0 to 54 K |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Option Exercise | M | 0.00 | 1,105 | 0 | 2,211 | |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Option Exercise | A | 0.00 | 9,518 | 0 | 9,518 | |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Option Exercise | M | 0.00 | 1,255 | 0 | 1,255 | |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Buy | M | 0.00 | 1,105 | 0 | 86,075 | 85 K to 86.1 K (+1.30 %) |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Buy | M | 0.00 | 1,255 | 0 | 84,970 | 83.7 K to 85 K (+1.50 %) |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | ANDO GORAN | Director | Option Exercise | M | 0.00 | 1,105 | 0 | 2,211 | |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | ANDO GORAN | Director | Option Exercise | A | 0.00 | 9,518 | 0 | 9,518 | |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | ANDO GORAN | Director | Option Exercise | M | 0.00 | 1,255 | 0 | 1,255 | |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | ANDO GORAN | Director | Buy | M | 0.00 | 1,105 | 0 | 5,181 | 4.1 K to 5.2 K (+27.11 %) |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | ANDO GORAN | Director | Buy | M | 0.00 | 1,255 | 0 | 4,076 | 2.8 K to 4.1 K (+44.49 %) |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Option Exercise | M | 0.00 | 1,105 | 0 | 2,211 | |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Option Exercise | A | 0.00 | 9,518 | 0 | 9,518 | |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Option Exercise | M | 0.00 | 1,255 | 0 | 1,255 | |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Buy | M | 0.00 | 1,105 | 0 | 5,511 | 4.4 K to 5.5 K (+25.08 %) |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Buy | M | 0.00 | 1,255 | 0 | 4,406 | 3.2 K to 4.4 K (+39.83 %) |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Option Exercise | M | 0.00 | 1,105 | 0 | 1,105 | |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Option Exercise | A | 0.00 | 9,518 | 0 | 9,518 | |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Option Exercise | M | 0.00 | 1,255 | 0 | 1,255 | |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Buy | M | 0.00 | 1,105 | 0 | 14,876 | 13.8 K to 14.9 K (+8.02 %) |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Buy | M | 0.00 | 1,255 | 0 | 13,771 | 12.5 K to 13.8 K (+10.03 %) |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | MICATI VICTOR P | Director | Option Exercise | M | 0.00 | 1,105 | 0 | 2,211 | |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | MICATI VICTOR P | Director | Option Exercise | A | 0.00 | 9,518 | 0 | 9,518 | |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | MICATI VICTOR P | Director | Option Exercise | M | 0.00 | 1,255 | 0 | 1,255 | |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | MICATI VICTOR P | Director | Buy | M | 0.00 | 1,105 | 0 | 5,181 | 4.1 K to 5.2 K (+27.11 %) |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | MICATI VICTOR P | Director | Buy | M | 0.00 | 1,255 | 0 | 4,076 | 2.8 K to 4.1 K (+44.49 %) |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | SALISBURY ROBERT C | Director | Option Exercise | M | 0.00 | 1,105 | 0 | 2,211 | |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | SALISBURY ROBERT C | Director | Option Exercise | A | 0.00 | 9,518 | 0 | 9,518 | |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | SALISBURY ROBERT C | Director | Option Exercise | M | 0.00 | 1,255 | 0 | 1,255 | |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | SALISBURY ROBERT C | Director | Buy | M | 0.00 | 1,105 | 0 | 9,212 | 8.1 K to 9.2 K (+13.63 %) |
Jul 03 2007 | ENZN | ENZON PHARMACEUTIC ... | SALISBURY ROBERT C | Director | Buy | M | 0.00 | 1,255 | 0 | 8,107 | 6.9 K to 8.1 K (+18.32 %) |
May 14 2007 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Buy | P | 8.19 | 1,000 | 8,190 | 52,000 | 51 K to 52 K (+1.96 %) |
Apr 12 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Sell | J | 8.22 | 400 | 3,288 | 0 | 400 to 0 (-100.00 %) |
Apr 12 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Sell | J | 8.23 | 2,390 | 19,670 | 400 | 2.8 K to 400 (-85.66 %) |
Apr 12 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Sell | J | 8.25 | 3,300 | 27,225 | 2,790 | 6.1 K to 2.8 K (-54.19 %) |
Apr 12 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Sell | J | 8.26 | 500 | 4,130 | 6,090 | 6.6 K to 6.1 K (-7.59 %) |
Apr 12 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Sell | J | 8.27 | 700 | 5,789 | 6,590 | 7.3 K to 6.6 K (-9.60 %) |
Apr 12 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Sell | J | 8.28 | 2,710 | 22,439 | 7,290 | 10 K to 7.3 K (-27.10 %) |
Apr 12 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 8.28 | 2,710 | 22,439 | 10,000 | 7.3 K to 10 K (+37.17 %) |
Apr 12 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 8.27 | 700 | 5,789 | 7,290 | 6.6 K to 7.3 K (+10.62 %) |
Apr 12 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 8.26 | 500 | 4,130 | 6,590 | 6.1 K to 6.6 K (+8.21 %) |
Apr 12 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 8.25 | 3,300 | 27,225 | 6,090 | 2.8 K to 6.1 K (+118.28 %) |
Apr 12 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 8.23 | 2,390 | 19,670 | 2,790 | 400 to 2.8 K (+597.50 %) |
Apr 12 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 8.22 | 400 | 3,288 | 400 | 0 to 400 |
Apr 12 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Sell | J | 8.25 | 10,253 | 84,587 | 0 | 10.3 K to 0 (-100.00 %) |
Apr 12 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 8.25 | 10,253 | 84,587 | 10,253 | 0 to 10.3 K |
Apr 11 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Sell | J | 8.20 | 11,300 | 92,660 | 0 | 11.3 K to 0 (-100.00 %) |
Apr 11 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Sell | J | 8.25 | 34,000 | 280,500 | 11,300 | 45.3 K to 11.3 K (-75.06 %) |
Apr 11 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 8.25 | 34,000 | 280,500 | 45,300 | 11.3 K to 45.3 K (+300.88 %) |
Apr 11 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 8.20 | 11,300 | 92,660 | 11,300 | 0 to 11.3 K |
Mar 06 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Sell | J | 8.19 | 700 | 5,733 | 0 | 700 to 0 (-100.00 %) |
Mar 06 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Sell | J | 8.20 | 852 | 6,986 | 700 | 1.6 K to 700 (-54.90 %) |
Mar 06 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Sell | J | 8.73 | 40,000 | 349,200 | 1,552 | 41.6 K to 1.6 K (-96.26 %) |
Mar 06 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Sell | J | 8.25 | 40,000 | 330,000 | 41,552 | 81.6 K to 41.6 K (-49.05 %) |
Mar 06 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Sell | J | 8.26 | 30,000 | 247,800 | 81,552 | 111.6 K to 81.6 K (-26.89 %) |
Mar 06 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 8.26 | 30,000 | 247,800 | 111,552 | 81.6 K to 111.6 K (+36.79 %) |
Mar 06 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 8.25 | 40,000 | 330,000 | 81,552 | 41.6 K to 81.6 K (+96.26 %) |
Mar 06 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 8.23 | 40,000 | 329,200 | 41,552 | 1.6 K to 41.6 K (+2,577.32 %) |
Mar 06 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 8.20 | 852 | 6,986 | 1,552 | 700 to 1.6 K (+121.71 %) |
Mar 06 2007 | ENZN | ENZON PHARMACEUTIC ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 8.19 | 700 | 5,733 | 700 | 0 to 700 |
Feb 20 2007 | ENZN | ENZON PHARMACEUTIC ... | Highbridge International LLC | 10% Owner | Sell | J | 8.76 | 30,000 | 262,800 | 0 | 30 K to 0 (-100.00 %) |
Feb 20 2007 | ENZN | ENZON PHARMACEUTIC ... | Highbridge International LLC | 10% Owner | Sell | J | 8.75 | 8,368 | 73,220 | 30,000 | 38.4 K to 30 K (-21.81 %) |
Feb 20 2007 | ENZN | ENZON PHARMACEUTIC ... | Highbridge International LLC | 10% Owner | Sell | J | 8.74 | 8,743 | 76,414 | 38,368 | 47.1 K to 38.4 K (-18.56 %) |
Feb 20 2007 | ENZN | ENZON PHARMACEUTIC ... | Highbridge International LLC | 10% Owner | Sell | J | 8.73 | 9,065 | 79,137 | 47,111 | 56.2 K to 47.1 K (-16.14 %) |